SOUTH PLAINFIELD, NJ — (Marketwired) — 03/08/17 — , (NASDAQ: COOL) today announced it has appointed Jeff Dyer, MBA, PhD, expert in business strategy and innovation to its Board of Directors."As we bring the vision of PolarityTE to fruition, we are excited to announce the appointment of a world class business strategist and scholar in innovation like Jeff Dyer to our Board of Directors. His career both working in the formative years of Bain & Company and studying the most innovative
SOUTH PLAINFIELD, NJ — (Marketwired) — 02/28/17 — , (NASDAQ: COOL) today announced it has appointed Burke Powers as Vice President of Product Development. Mr. Powers has extensive experience building and commercializing products both in healthcare and other sectors utilizing artificial intelligence and big data anlytics."The addition of Burke Powers to PolarityTE marks yet another major milestone as we assemble the pieces to fulfill our vision to approach tissue engineering from a new p
SOUTH PLAINFIELD, NJ — (Marketwired) — 02/22/17 — , (NASDAQ: COOL) today announced it has received formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") notifying PolarityTE that it has regained compliance with Listing Rule 5605(b)(1), the independent director requirement for continued listing on The NASDAQ Stock Market, with the appointment of Mr. Steve Gorlin and Dr. Jon Mogford, and that the matter is now closed. PolarityTE–s commo
SOUTH PLAINFIELD, NJ — (Marketwired) — 02/16/17 — , (NASDAQ: COOL) today announced it has appointed Jon Mogford, PhD to the Board of Directors. Dr. Mogford has extensive experience in regenerative medicine and wound healing, with a long track record of leading large research institutions. He currently oversees research strategy as Vice Chancellor for Research across the entire Texas A&M University System, and led significant expansion and collaborations while serving as Deputy Director o
SOUTH PLAINFIELD, NJ — (Marketwired) — 02/09/17 — (NASDAQ: COOL) today announced it has appointed Steve Gorlin to the Board of Directors. Mr. Gorlin has extensive experience building successful biotechnology companies, and is a leader in regenerative medicine, pharmaceutical drug and medical device research and development."We are extremely excited to announce Steve Gorlin as a new member of the PolarityTE Board of Directors. With over 40 successful years in the field, he remains a lea
SOUTH PLAINFIELD, NJ — (Marketwired) — 01/10/17 — (NASDAQ: COOL) following its previous announcement that it signed a definitive merger agreement with a Nevada corporation , (the "Merger") today announced that the Company–s name has been changed to PolarityTE, Inc., effective with The NASDAQ Capital Market at the open of business on January 11, 2017. The Company–s new CUSIP will be 731094108 and its common stock will continue to trade under the symbol "COOL.""Ch
SOUTH PLAINFIELD, NJ — (Marketwired) — 01/09/17 — (NASDAQ: COOL) following announcement that it had signed a definitive merger agreement with , (the "Merger") supplements its esteemed Clinical Board of Advisors with more innovative thought leaders in plastic and reconstructive surgery and regenerative medicine with Drs. Bentz, Bluebond-Langner, and Katz. Denver Lough MD, PhD, Chairman and CEO, remarked, "PolarityTE is focused on delivering transformative tissue engineering p
Dr. Neumeister has previously served as President of the Plastic Surgery Foundation, Plastic Surgery Research Council and a Leader in Translational Regenerative Medicine
Appoints Denver Lough, MD, PhD as Chief Executive Officer and Chairman of the Board; Appoints Edward Swanson, MD as Chief Operating Officer and Director; Executive Vice President John Stetson named Director; Majesco accepts subscription agreements for $2.25 million
